BR112022002328A2 - Transplante autólogo de tecido tímico - Google Patents

Transplante autólogo de tecido tímico

Info

Publication number
BR112022002328A2
BR112022002328A2 BR112022002328A BR112022002328A BR112022002328A2 BR 112022002328 A2 BR112022002328 A2 BR 112022002328A2 BR 112022002328 A BR112022002328 A BR 112022002328A BR 112022002328 A BR112022002328 A BR 112022002328A BR 112022002328 A2 BR112022002328 A2 BR 112022002328A2
Authority
BR
Brazil
Prior art keywords
thymic tissue
autologous
tissue transplantation
autologous thymic
thymic
Prior art date
Application number
BR112022002328A
Other languages
English (en)
Inventor
Lagasse Eric
Original Assignee
Univ Pittsburgh Commonwealth Sys Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh Commonwealth Sys Higher Education filed Critical Univ Pittsburgh Commonwealth Sys Higher Education
Publication of BR112022002328A2 publication Critical patent/BR112022002328A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)

Abstract

transplante autólogo de tecido tímico. a presente revelação fornece métodos e kits para preservar ou restaurar as funções tímicas de um indivíduo que deles necessita. os métodos e kits aqui revelados incluem a distribuição de um tecido tímico autólogo em pelo menos um gânglio linfático do indivíduo.
BR112022002328A 2019-08-05 2020-08-05 Transplante autólogo de tecido tímico BR112022002328A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962882887P 2019-08-05 2019-08-05
PCT/US2020/044940 WO2021026195A1 (en) 2019-08-05 2020-08-05 Autologous thymic tissue transplantation

Publications (1)

Publication Number Publication Date
BR112022002328A2 true BR112022002328A2 (pt) 2022-04-19

Family

ID=74504129

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022002328A BR112022002328A2 (pt) 2019-08-05 2020-08-05 Transplante autólogo de tecido tímico

Country Status (12)

Country Link
US (1) US20220152114A1 (pt)
EP (1) EP4009990A4 (pt)
JP (1) JP2022543149A (pt)
KR (1) KR20220044313A (pt)
CN (1) CN114728023A (pt)
AU (1) AU2020326709A1 (pt)
BR (1) BR112022002328A2 (pt)
CA (1) CA3146580A1 (pt)
GB (1) GB2603310A (pt)
IL (1) IL290284A (pt)
MX (1) MX2022001508A (pt)
WO (1) WO2021026195A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1866409B1 (en) * 2005-04-06 2011-10-12 Duke University Parathyroid and thymus transplantation in digeorge syndrome subjects
US11191785B2 (en) * 2008-03-07 2021-12-07 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
WO2014138486A1 (en) * 2013-03-06 2014-09-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
CN103596854B (zh) * 2011-04-14 2018-07-17 雷蒙德·U·奥萨罗吉亚格本 淋巴结样品收集试剂盒与使用该试剂盒诊断肺癌的病理学分析方法
WO2014127198A1 (en) * 2013-02-15 2014-08-21 Joslin Diabetes Center Thymic regeneration

Also Published As

Publication number Publication date
US20220152114A1 (en) 2022-05-19
MX2022001508A (es) 2022-05-10
EP4009990A4 (en) 2023-08-09
JP2022543149A (ja) 2022-10-07
EP4009990A1 (en) 2022-06-15
CA3146580A1 (en) 2021-02-11
WO2021026195A1 (en) 2021-02-11
IL290284A (en) 2022-04-01
CN114728023A (zh) 2022-07-08
AU2020326709A1 (en) 2022-02-24
KR20220044313A (ko) 2022-04-07
GB202202533D0 (en) 2022-04-13
GB2603310A (en) 2022-08-03

Similar Documents

Publication Publication Date Title
CL2019002897A1 (es) Tratamiento para el asma con anticuerpo anti-tslp.
BR112018000768A2 (pt) anticorpos anti-pd-1, anticorpos anti-pd-1 ativáveis e métodos de uso dos mesmos
BR112018002824A2 (pt) anticorpo, polinucleotídeo, vetor, célula, métodos para expressar o anticorpo, para tratar uma condição associada com pd-1 e para tratar uma condição em um sujeito, kit, composição farmacêutica e uso do anticorpo
AR108468A1 (es) POLIPÉPTIDOS DE FUSIÓN CD40L-Fc Y MÉTODOS DE USO DE LOS MISMOS
ECSP21052194A (es) Tratamiento agudo y tratamiento rápido de la cefalea usando anticuerpos anti-cgrp
BR112017003620A2 (pt) métodos de tratamento de mieloma múltiplo com compostos imunomoduladores em combinação com anticorpos
BR112018009311A8 (pt) ?método para tratar um sujeito humano sofrendo de tma persistente associada com transplante de célula tronco hematopoiética?
EA202190073A1 (ru) Композиции и способы лечения видов гемоглобинопатии и талассемии
BR112018001232A2 (pt) pd-l1 que expressa células-tronco hematopoéticas e usos
BR112015030356A2 (pt) métodos de tratamento de uma taupatia
CO2020014510A2 (es) Estimulador de treg selectivo rur20kd-il-2 y composiciones relacionadas
ECSP21052193A (es) Tratamiento de cefalea por uso excesivo de medicamentos usando anticuerpos anti-cgrp o anti-cgrp-r
CO2021010786A2 (es) Toxinas apxia, apxiia y apxiiia inactivadas
MX2020012613A (es) Composiciones y usos de las mismas para el tratamiento de enfermedades o afecciones.
CL2022001554A1 (es) Anticuerpos anti-mertk y métodos de uso de los mismos
BR112021012056A2 (pt) Inibidor da expressão gênica do hbv, agente que reduz a carga antigênica de hbv, composições para uso no tratamento de uma infecção crônica por hbv, usos de um inibidor da expressão gênica do hbv e de um agente que reduz a carga antigênica de hbv, métodos de tratamento da infecção crônica por hbv e kit
CO2019002608A2 (es) Biomarcadores de arn para angioedema hereditario
CO2021003078A2 (es) Anticuerpos de anti-cd33 y métodos para usarlos
CL2021001246A1 (es) Moduladores de expresión irf5.
PE20210109A1 (es) Moduladores de la expresion de irf4
ECSP21017326A (es) Composiciones alimenticias y composiciones de aditivos para piensos para especies de acuicultura
CL2018002136A1 (es) Combinaciones de dihidrocloruro de histamina y uso de estas
WO2016057536A8 (en) Methods for preparing donor tissue for transplantation
CL2021002866A1 (es) Tratamiento de la cefalea usando anticuerpos anti-cgrp.
BR112022002328A2 (pt) Transplante autólogo de tecido tímico